A new study from the University of Florida Health, published in the Annals of Family Medicine, challenges the...

Roles requiring high levels of emotional engagement and confrontation, such as those in healthcare, education, and...

A new clinical trial led by an Indiana University School of Medicine researcher has revealed that semaglutide, a...

GLP-1 receptor agonist liraglutide, typically prescribed for type 2 diabetes and obesity, significantly reduced monthly...

A clinical trial has found that combining standard insulin therapy with the investigational drug dapagliflozin can...

A new study found that dapagliflozin, a sodium glucose cotransporter 2 (SGLT-2) inhibitor, improved key liver conditions...

A study published in JAMA Network Open reveals that sustained weight loss in early middle age can lead to major health...

A new study led by Brigham Young University (BYU) in collaboration with German research institutions has found that...

This research article is published in the Case Reports in Clinical Radiology, published by Scientific...

Micro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin for...

New Delhi: A new analysis by the University of Oxford has found that people taking GLP-1 weight loss drugs typically...

A new study published in Nature Metabolism by researchers at Sweden's Karolinska Institutet suggests that women may be...